| dc.contributor.author | Kaltalioglu*, Kaan | en_US |
| dc.contributor.author | Balabanli, Barbaros | en_US |
| dc.contributor.author | Coskun-Cevher, Sule | en_US |
| dc.date.accessioned | 1399-07-08T22:08:38Z | fa_IR |
| dc.date.accessioned | 2020-09-29T22:08:38Z | |
| dc.date.available | 1399-07-08T22:08:38Z | fa_IR |
| dc.date.available | 2020-09-29T22:08:38Z | |
| dc.date.issued | 2019-04-01 | en_US |
| dc.date.issued | 1398-01-12 | fa_IR |
| dc.date.submitted | 2018-11-12 | en_US |
| dc.date.submitted | 1397-08-21 | fa_IR |
| dc.identifier.citation | Kaltalioglu*, Kaan, Balabanli, Barbaros, Coskun-Cevher, Sule. (2019). Alleviation of Cisplatin-Induced Hepatotoxic Damage: the Synergistic Effect of Morin and Hesperidin against Oxidative Stress. Research Journal of Pharmacognosy, 6(2), 9-18. doi: 10.22127/rjp.2019.84314 | en_US |
| dc.identifier.issn | 2345-4458 | |
| dc.identifier.issn | 2345-5977 | |
| dc.identifier.uri | https://dx.doi.org/10.22127/rjp.2019.84314 | |
| dc.identifier.uri | http://www.rjpharmacognosy.ir/article_84314.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/126001 | |
| dc.description.abstract | <strong>Background and objectives:</strong> A key aspect of cisplatin-induced hepatotoxicity is oxidative stress. The current study was conducted to show, for the first time, the restoring and synergistic effects of morin and hesperidin against oxidative stress in hepatotoxicity. <strong>Methods:</strong> Fourty-two Wistar albino rats were randomly divided into seven groups: group A (control), group B (morin), group C (hesperidin), group D (cisplatin), group E (cisplatin+morin), group F (cisplatin+hesperidin), group G (cisplatin+morin+hesperidin). Throughout ten consecutive days, morin and/or hesperidin were given to rats and cisplatin was injected as a single dose (7 mg/kg) on the 4<sup>th</sup> day, and then the rats were sacrificed on the 11<sup>th</sup> day. Liver tissue samples collected from the rats were used for the measurement of malondialdehyde, nitric oxide, glutathione levels as well as myeloperoxidase, catalase and superoxide dismutase activities. <strong>Results:</strong> Administration of cisplatin elevated the malondialdehyde and nitric oxide levels and also reduced the glutathione levels and catalase activity in the liver. However, in the morin and/or hesperidin groups, glutathione level and catalase activity were higher but malondialdehyde and nitric oxide levels and myeloperoxidase activity were lower than the cisplatin-induced group. <strong>Conclusion:</strong> Our results indicated that pretreatment with these flavonoids can be used as protective treatment for cisplatin-induced hepatotoxicity. | en_US |
| dc.format.extent | 501 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | - The Iranian Society of Pharmacognosy
- Shahid Beheshti University of Medical Sciences | en_US |
| dc.relation.ispartof | Research Journal of Pharmacognosy | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.22127/rjp.2019.84314 | |
| dc.subject | Cisplatin | en_US |
| dc.subject | hepatotoxicity | en_US |
| dc.subject | hesperidin | en_US |
| dc.subject | morin | en_US |
| dc.subject | oxidative stress | en_US |
| dc.subject | Hepatotoxicity | en_US |
| dc.subject | Oxidative stress | en_US |
| dc.title | Alleviation of Cisplatin-Induced Hepatotoxic Damage: the Synergistic Effect of Morin and Hesperidin against Oxidative Stress | en_US |
| dc.type | Text | en_US |
| dc.type | Original paper | en_US |
| dc.contributor.department | Espiye Vocational School, Giresun University, 28600, Giresun, Turkey | en_US |
| dc.contributor.department | Biology Department, Science Faculty, Gazi University, 06500, Ankara, Turkey | en_US |
| dc.contributor.department | Biology Department, Science Faculty, Gazi University, 06500, Ankara, Turkey | en_US |
| dc.citation.volume | 6 | |
| dc.citation.issue | 2 | |
| dc.citation.spage | 9 | |
| dc.citation.epage | 18 | |
| nlai.contributor.orcid | 0000-0002-4995-2657 | |